2008_106
Archive ID: 2008_106Daria Hazuda from Merck & Co explains the virology of HIV and talks about the past clinical studies on antiretroviral therapy, in particular on integrase inhibitors, which she has been involved in at Merck. She also reflects on HIV as an exceptional virus and on how to influence a new generation of HIV researchers.
Background material
"When we think of the dramatic development of antiretroviral drugs that has happened since the start of HIV/AIDS in 1981, we should think of people like Daria Hazuda from Merck. She has been instrumental in developing several of the functioning ARV medications. She is also a friend and I have interviewed her several times." - Staffan Hildebrand